Literature DB >> 17009410

Necrosis of a large hepatic tumor after hemorrhage and subsequent selective arterial embolization.

Volkert A L Huurman1, Jan H M B Stoot, Edwin van der Linden, Onno T Terpstra, Alexander F M Schaapherder.   

Abstract

This case report describes a young female patient presenting with acute intra-abdominal hemorrhage originating from a large tumor in the liver, most likely a hepatocellular adenoma. The bleeding was stopped by selective embolization of right hepatic artery branches. Subsequently, partial hepatectomy was performed after 6 mo. Macro- and microscopic examination showed complete necrosis and absence of tumorous tissue. The patient was discharged without complications, and subsequent follow-up until 22 mo after resection did not reveal any new lesions in the liver. This case emphasizes the significance of selective arterial embolization in the management of bleeding liver tumors and questions the need for (partial) hepatectomy after this procedure in selective cases.

Entities:  

Mesh:

Year:  2006        PMID: 17009410      PMCID: PMC4124419          DOI: 10.3748/wjg.v12.i37.6059

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

2.  Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal.

Authors:  T Terkivatan; J H de Wilt; R A de Man; R R van Rijn; P E Zondervan; H W Tilanus; J N IJzermans
Journal:  Arch Surg       Date:  2001-09

3.  Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings.

Authors:  H Iijima; Y Moriwaki; T Yamamoto; S Takahashi; T Nishigami; T Hada
Journal:  Intern Med       Date:  2001-09       Impact factor: 1.271

4.  Rapid disappearance of hepatic adenoma after contraceptive withdrawal.

Authors:  P Aseni; C V Sansalone; C Sammartino; F D Benedetto; G Carrafiello; A Giacomoni; C Osio; M Vertemati; D Forti
Journal:  J Clin Gastroenterol       Date:  2001-09       Impact factor: 3.062

5.  Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.

Authors:  J B Rooks; H W Ory; K G Ishak; L T Strauss; J R Greenspan; A P Hill; C W Tyler
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

6.  Selective management of hepatic adenomas.

Authors:  G T Ault; S M Wren; P W Ralls; T B Reynolds; S C Stain
Journal:  Am Surg       Date:  1996-10       Impact factor: 0.688

Review 7.  Hepatic adenoma and focal nodular hyperplasia.

Authors:  C K Shortell; S I Schwartz
Journal:  Surg Gynecol Obstet       Date:  1991-11

8.  Non-operative arterial embolisation in primary liver tumours.

Authors:  P G Wheeler; W Melia; P Dubbins; B Jones; H Nunnerley; P Johnson; R Williams
Journal:  Br Med J       Date:  1979-07-28

9.  [Spontaneous rupture of hepatic focal nodular hyperplasia--a rare cause of acute intraabdominal bleedingf].

Authors:  A Kleespies; U Settmacher; P Neuhaus
Journal:  Zentralbl Chir       Date:  2002-04       Impact factor: 0.942

10.  Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.

Authors:  P Parker; I Burr; A Slonim; F K Ghishan; H Greene
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

  10 in total
  2 in total

1.  LATE SURGICAL TREATMENT FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR ADENOMA: CASE REPORT.

Authors:  Luis Eduardo Veras Pinto; João Paulo Ribeiro Silva; Gustavo Coêlho Rêgo; José Huygens Parente Garcia
Journal:  Arq Bras Cir Dig       Date:  2015 Nov-Dec

2.  Surgical management of spontaneous ruptured hepatocellular adenoma.

Authors:  Marcelo Augusto Fontenelle Ribeiro Junior; Eleazar Chaib; William Abrão Saad; Luiz Augusto Carneiro D'Albuquerque; Ivan Cecconello
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.